Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family
暂无分享,去创建一个
Richard Wade-Martins | J. Paul Bolam | David M. Bannerman | S. Chandra | S. Cragg | J. Bolam | D. Bannerman | R. Deacon | S. Threlfell | V. Buchman | O. Peters | Natalie M. Doig | R. Wade-Martins | Natalie Connor-Robson | Natalia Ninkina | Vladimir L. Buchman | Sarah Threlfell | Stephanie J. Cragg | Gurdeep Kooner | Gurdeep Kooner | N. Ninkina | Sabina Anwar | Owen Peters | Steven Millership | Natalie Doig | Natalie Connor-Robson | Robert M. Deacon | Sreeganga S. Chandra | Steven J. Millership | Sabina Anwar | Stephaine J. Cragg | N. Doig
[1] John Sharkey,et al. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice , 2004 .
[2] A. Davies,et al. Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene , 2003, Molecular and Cellular Biology.
[3] H. Niznik,et al. Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] H. Tanila,et al. Role of alpha-synuclein in presynaptic dopamine recruitment. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] S. Cragg,et al. α-Synuclein and dopamine at the crossroads of Parkinson's disease , 2010, Trends in Neurosciences.
[6] S. Cragg,et al. Increased striatal dopamine release and hyperdopaminergic‐like behaviour in mice lacking both alpha‐synuclein and gamma‐synuclein , 2008, The European journal of neuroscience.
[7] M. Zigmond,et al. A role for alpha-synuclein in the regulation of dopamine biosynthesis. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[9] Sonja W. Scholz,et al. SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.
[10] A. Davies,et al. Persyn, a Member of the Synuclein Family, Has a Distinct Pattern of Expression in the Developing Nervous System , 1998, The Journal of Neuroscience.
[11] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[12] A. Björklund,et al. Dopamine neuron systems in the brain: an update , 2007, Trends in Neurosciences.
[13] M. Zigmond,et al. A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis , 2002, The Journal of Neuroscience.
[14] Jochen Roeper,et al. Individual dopamine midbrain neurons: Functional diversity and flexibility in health and disease , 2008, Brain Research Reviews.
[15] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[16] Masahiko Watanabe,et al. Calbindin 1, fibroblast growth factor 20, and α-synuclein in sporadic Parkinson’s disease , 2008, Human Genetics.
[17] J. Schwartz,et al. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum , 1976, Psychopharmacology.
[18] J. Trojanowski,et al. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. , 2002, Neurotoxicology.
[19] S. Cragg,et al. α6-Containing Nicotinic Acetylcholine Receptors Dominate the Nicotine Control of Dopamine Neurotransmission in Nucleus Accumbens , 2008, Neuropsychopharmacology.
[20] S. Cragg,et al. Dopamine Release and Uptake Dynamics within Nonhuman Primate Striatum In Vitro , 2000, The Journal of Neuroscience.
[21] J. Bolam,et al. A Dopaminergic Axon Lattice in the Striatum and Its Relationship with Cortical and Thalamic Terminals , 2008, The Journal of Neuroscience.
[22] A. Sidhu,et al. Attenuation of dopamine transporter activity by alpha-synuclein. , 2003, Neuroscience letters.
[23] K. Channon,et al. The effect of α‐synuclein knockdown on MPP+ toxicity in models of human neurons , 2008, The European journal of neuroscience.
[24] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[25] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[26] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[27] B. Ghetti,et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. , 2010, Brain : a journal of neurology.
[28] R. Wightman,et al. Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] L. Stefanis,et al. α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells , 2005, Journal of Cell Science.
[30] J. Davis,et al. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[31] V. Buchman,et al. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. , 2004, Journal of neurochemistry.
[32] P. Chan,et al. Silencing α-Synuclein Gene Expression Enhances Tyrosine Hydroxylase Activity in MN9D Cells , 2008, Neurochemical Research.
[33] Erica L. Unger,et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice , 2006, Neurobiology of Disease.
[34] T. Hastings,et al. Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells , 2006, Journal of neurochemistry.
[35] V. Buchman,et al. γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein , 2009, Human molecular genetics.
[36] A. Sidhu,et al. Attenuation of dopamine transporter activity by α-synuclein , 2003, Neuroscience Letters.
[37] S. Chandra,et al. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction , 2010, Proceedings of the National Academy of Sciences.
[38] K. Doheny,et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.
[39] V. Buchman,et al. Edinburgh Research Explorer Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice , 2010 .
[40] Leonidas Stefanis,et al. α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.
[41] Helmut L. Haas,et al. Functional diversity of ventral midbrain dopamine and GABAergic neurons , 2004, Molecular Neurobiology.
[42] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[43] A. Morris,et al. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. , 1998, Biochemistry.
[44] Heikki Tanila,et al. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein , 2005, Neurobiology of Disease.
[45] J. Broman,et al. Different basal levels of CaMKII phosphorylated at Thr286/287 at nociceptive and low‐threshold primary afferent synapses , 2005, The European journal of neuroscience.
[46] Giuseppe Battaglia,et al. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Hawkins,et al. α‐Synuclein produces a long‐lasting increase in neurotransmitter release , 2004, The EMBO journal.
[48] S. Cragg,et al. Nicotine amplifies reward-related dopamine signals in striatum , 2004, Nature Neuroscience.
[49] Richard Paylor,et al. Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.
[50] H. Tanila,et al. Role of α-Synuclein in Presynaptic Dopamine Recruitment , 2004, The Journal of Neuroscience.
[51] S. Cragg. Variable Dopamine Release Probability and Short-Term Plasticity between Functional Domains of the Primate Striatum , 2003, The Journal of Neuroscience.
[52] R. Hen,et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Sulzer,et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.
[54] R. Nicoll,et al. Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis , 2010, Neuron.
[55] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[56] E. Masliah,et al. A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.
[57] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.